middle.news
Hydration Pharmaceuticals Reports $2.86M Loss, Eyes Strategic Moves Amid Trading Halt
12:42pm on Friday 1st of May, 2026 AEST
•
Healthcare
Read Story
Hydration Pharmaceuticals Reports $2.86M Loss, Eyes Strategic Moves Amid Trading Halt
12:42pm on Friday 1st of May, 2026 AEST
Key Points
FY25 net loss of $2.86 million after prior year profit
Revenue decline due to SKU and channel rationalisation
Significant cost-cutting and headcount reduction ongoing
Board changes with new director appointment and resignation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
The Hydration Pharmaceuticals Company (ASX:HPC)
OPEN ARTICLE